̽»¨¾«Ñ¡

My laboratory works on tuberculosis. 

I have more than 15 years of research experience with intracellular
pathogens, primarily Mycobacterium species, under Biosafety Level 2 (BSL2)
and BSL3, and in mouse models. I am Chairman of the Biosafety Committee at
̽»¨¾«Ñ¡ and help oversee KI's regulations on biosafety,
containment work in different biosafety levels and the handling of
genetically-modified microorganisms. I am also Director of the BSL3 core
facility at Biomedicum which supports research on risk group 3 bacteria,
parasites and viruses.

Associate Professor of Immunology (Docent), ̽»¨¾«Ñ¡. 2014
Doctor of Medical Science (PhD) in Immunobiology, ̽»¨¾«Ñ¡. 2004
Master of Medical Science with a Major in Biomedicine, ̽»¨¾«Ñ¡. 1999

My laboratory does basic research on the immunology and infection biology of
mycobacteria. We are particularly interested in the aerobiology of
Mycobacterium tuberculosis and in techniques to capture and analyze
pathogens in the air. We have developed an aerobiology platform in BSL3 where
highly-pathogenic microorganisms can be safely and experimentally
aerosolized, collected using different air samplers and detected by different
analytical methods. We are using this platform to investigate the performance
of an electrostatic air sampler for M. tuberculosis developed in the lab;
to investigate biosafety and sampling performance of commercial samplers; and
to study the effects of aerosol transport on the survival, infectivity and
immune response of M. tuberculosis and SARS-CoV-2.

Coordinator, KI Summer School in Medical Research (KISS)
Teacher, Basic Laboratory Safety (course 2690)
Teacher, Immunology and Microbiology (course 1BI041)